May 25 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) [ZSE:3JDG2] said it carried out a capital increase by 276,510 euro ($298,000) by an issue of 21,270 new ordinary shares.
The share capital of the company after the increase amounts to 16.3 million euro and is divided into 1,255,025 ordinary shares, with a nominal amount of 13 euro, it said in a filing to the Zagreb bourse late on Wednesday.
The capital increase is in accordance with the decision of the management board of the company taken on April 13, it added.
Founded in 1991, JGL is one of the largest drug makers in Croatia, specialising in the production of sterile nose, eye and ear drop solutions. JGL operates in some 60 markets around the world.
The company has corporate bonds listed on the Zagreb Stock Exchange.
($ = 0.929 euro)